PARAMETRIC PORTFOLIO ASSOCIATES LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 102 filers reported holding ANTARES PHARMA INC in Q1 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$1,086,000
+79.5%
264,913
+56.2%
0.00%
Q4 2021$605,000
+13.3%
169,579
+15.5%
0.00%
Q3 2021$534,000
-5.5%
146,765
+13.4%
0.00%
Q2 2021$565,000
+89.0%
129,473
+78.3%
0.00%
Q1 2021$299,000
+32.3%
72,631
+28.4%
0.00%
Q4 2020$226,000
+50.7%
56,552
+1.6%
0.00%
Q3 2020$150,000
+26.1%
55,672
+28.6%
0.00%
Q2 2020$119,000
-27.4%
43,287
-37.8%
0.00%
Q1 2020$164,000
-89.0%
69,598
-78.0%
0.00%
-100.0%
Q4 2019$1,489,000
+401.3%
316,888
+256.4%
0.00%
Q3 2019$297,000
+14.7%
88,909
+13.1%
0.00%
Q2 2019$259,000
-26.0%
78,595
-32.0%
0.00%
Q1 2019$350,000
+10.8%
115,661
-0.6%
0.00%
Q4 2018$316,000
+754.1%
116,326
+944.3%
0.00%
Q3 2018$37,000
-17.8%
11,139
-36.4%
0.00%
Q2 2018$45,000
+21.6%
17,506
+5.1%
0.00%
Q1 2018$37,000
+42.3%
16,659
+26.2%
0.00%
Q4 2017$26,00013,2020.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2018
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 4,598,329$10,852,0004.99%
Soleus Capital Management, L.P. 864,100$2,039,0002.37%
Healthcare Value Capital, LLC 500,000$1,180,0001.98%
ORACLE INVESTMENT MANAGEMENT INC 1,227,114$2,896,0000.86%
PERKINS CAPITAL MANAGEMENT INC 232,166$548,0000.66%
Stonepine Capital Management, LLC 151,189$357,0000.38%
Zebra Capital Management LLC 84,963$200,0000.32%
Intrinsic Edge Capital Management LLC 1,000,000$2,360,0000.31%
Alambic Investment Management, L.P. 46,069$109,0000.26%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$473,0000.26%
View complete list of ANTARES PHARMA INC shareholders